These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19926784)

  • 21. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease.
    Blankenberg S; Rupprecht HJ; Bickel C; Jiang XC; Poirier O; Lackner KJ; Meyer J; Cambien F; Tiret L;
    J Am Coll Cardiol; 2003 Jun; 41(11):1983-9. PubMed ID: 12798569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
    Frisdal E; Klerkx AH; Le Goff W; Tanck MW; Lagarde JP; Jukema JW; Kastelein JJ; Chapman MJ; Guerin M
    Hum Mol Genet; 2005 Sep; 14(18):2607-18. PubMed ID: 16049032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TaqIB polymorphism in the cholesteryl ester transfer protein (CETP) gene influences lipid responses to the consumption of kiwifruit in hypercholesterolaemic men.
    Gammon CS; Minihane AM; Kruger R; Conlon CA; von Hurst PR; Jones B; Stonehouse W
    Br J Nutr; 2014 Mar; 111(6):1077-84. PubMed ID: 24176024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy.
    Barbosa EJ; Glad CA; Nilsson AG; Filipsson Nyström H; Götherström G; Svensson PA; Vinotti I; Bengtsson BÅ; Nilsson S; Boguszewski CL; Johannsson G
    Eur J Endocrinol; 2012 Sep; 167(3):353-62. PubMed ID: 22715478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
    van Acker BA; Botma GJ; Zwinderman AH; Kuivenhoven JA; Dallinga-Thie GM; Sijbrands EJ; Boer JM; Seidell JC; Jukema JW; Kastelein JJ; Jansen H; Verhoeven AJ;
    Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of cholesteryl ester transfer protein by glucocorticoids: a randomised study on HDL.
    Werumeus Buning J; Dimova LG; Perton FG; Tietge UJF; van Beek AP; Dullaart RPF
    Eur J Clin Invest; 2017 Jul; 47(7):494-503. PubMed ID: 28542805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. I405V and TaqIB polymorphisms of the cholesteryl ester transfer protein and their relation to serum lipid and lipoprotein levels in a Turkish population.
    Doğru-Abbasoğlu S; Parildar-Karpuzoğlu H; Depboylu B; Cine N; Uysal M; Aykaç-Toker G
    Cell Biochem Funct; 2009 Mar; 27(2):76-80. PubMed ID: 19165812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort.
    Schierer A; Been LF; Ralhan S; Wander GS; Aston CE; Sanghera DK
    Pharmacogenet Genomics; 2012 Feb; 22(2):95-104. PubMed ID: 22143414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma cholesteryl ester transfer protein and lipoprotein levels during treatment of growth hormone-deficient adult humans.
    Carrilho AJ; Cunha-Neto MB; Nunes VS; Lottenberg AM; Medina WL; Nakandakare ER; Musolino NR; Bronstein MD; Quintão EC
    Lipids; 2001 Jun; 36(6):549-54. PubMed ID: 11485157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of cholesterol ester transfer protein taqIB polymorphism on changes of serum lipid ratios induced by high-carbohydrate/low-fat diet in healthy youth].
    Du J; Fang DZ; Gong RR; Tang H; Huang X; Li RH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):684-8. PubMed ID: 19764573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of growth hormone replacement therapy on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone-deficient adults.
    Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
    J Lipid Res; 2000 Jun; 41(6):925-32. PubMed ID: 10828084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
    Inazu A; Brown ML; Hesler CB; Agellon LB; Koizumi J; Takata K; Maruhama Y; Mabuchi H; Tall AR
    N Engl J Med; 1990 Nov; 323(18):1234-8. PubMed ID: 2215607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. I405V and -629C/A polymorphisms of the cholesteryl ester transfer protein gene in patients with coronary artery disease.
    Ghatreh Samani K; Noori M; Rohbani Nobar M; Hashemzadeh Chaleshtori M; Farrokhi E; Darabi Amin M
    Iran Biomed J; 2009 Apr; 13(2):103-8. PubMed ID: 19471550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia.
    Inazu A; Koizumi J; Mabuchi H; Kajinami K; Takeda R
    Horm Metab Res; 1992 Jun; 24(6):284-8. PubMed ID: 1634194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
    Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
    O'Neal DN; Hew FL; Best JD; Alford F
    Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CETP genotypes and HDL-cholesterol phenotypes in the HERITAGE Family Study.
    Spielmann N; Leon AS; Rao DC; Rice T; Skinner JS; Bouchard C; Rankinen T
    Physiol Genomics; 2007 Sep; 31(1):25-31. PubMed ID: 17519358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness.
    Kakko S; Tamminen M; Päivänsalo M; Kauma H; Rantala AO; Lilja M; Reunanen A; Kesäniemi YA; Savolainen MJ
    Eur J Clin Invest; 2001 Jul; 31(7):593-602. PubMed ID: 11454014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.